Not Found

Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

* This is the Professional Version. *

Crigler-Najjar Syndrome

By Steven K. Herrine, MD, Thomas Jefferson University;Jefferson Medical College

Click here for
Patient Education

This rare inherited disorder is caused by deficiency of the enzyme glucuronyl transferase.

Patients with autosomal recessive type I (complete) disease have severe hyperbilirubinemia. They usually die of kernicterus by age 1 yr but may survive into adulthood. Treatment may include phototherapy and liver transplantation.

Patients with autosomal dominant type II (partial) disease (which has variable penetrance) often have less severe hyperbilirubinemia (< 20 mg/dL [< 342 μmol/L]) and usually live into adulthood without neurologic damage. Phenobarbital 1.5 to 2 mg/kg po tid, which induces the partially deficient glucuronyl transferase, may be effective.

Drugs Mentioned In This Article

  • Drug Name
    Select Trade
  • No US brand name

* This is the Professional Version. *